DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors
Condition(s):Glioblastoma or GliosarcomaLast Updated:July 16, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Glioblastoma or GliosarcomaLast Updated:July 16, 2018Completed
Condition(s):Gliosarcoma; Recurrent GlioblastomaLast Updated:August 26, 2022Completed
Condition(s):Glioblastoma; GliosarcomaLast Updated:November 14, 2014Completed
Condition(s):Glioblastoma; Gliosarcoma; Malignant GliomaLast Updated:November 28, 2023Recruiting
Condition(s):Glioblastoma; GliosarcomaLast Updated:November 9, 2018Terminated
Condition(s):Glioblastoma Multiforme of Brain; Glioma, SarcomatousLast Updated:April 13, 2023Recruiting
Condition(s):Glioblastoma; GliosarcomaLast Updated:November 6, 2015Withdrawn
Condition(s):Glioblastoma; GliosarcomaLast Updated:May 27, 2013Completed
Condition(s):Glioblastoma Multiforme; GBM; GliosarcomaLast Updated:December 9, 2014Unknown status
Condition(s):Adult Brain TumorsLast Updated:June 4, 2013Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.